Coherus BioSciences Inc (NAS:CHRS)
$ 1.76 -0.06 (-3.3%) Market Cap: 201.92 Mil Enterprise Value: 429.62 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 42/100

Q4 2018 Coherus BioSciences Inc Earnings Call Transcript

Feb 28, 2019 / 09:30PM GMT
Release Date Price: $14.34 (+2.21%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Coherus Biosciences Fourth Quarter Earnings Conference Call. My name is Michelle, and I will be your conference operator for the call today. (Operator Instructions) And as a reminder, this conference call is being recorded. I will now like to turn the call over to David Arrington, Vice President of Investor Relations and Corporate Affairs. Please go ahead.

David Arrington
Coherus BioSciences, Inc. - VP of IR & Corporate Affairs

Thank you, Michelle, and good afternoon, everyone. After close of market today, we issued our fourth quarter financial results press release. This release can be found on the Coherus Biosciences website.

Joining me today for the call will be: Coherus' CEO, Denny Lanfear; and our Chief Financial Officer, Jean Viret.

Before we begin our formal remarks, I would like to remind you that we will be making forward-looking statements with respect to product development plans, all of which involve certain assumptions, risks and uncertainties that are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot